AN2 Therapeutics, Inc. (ANTX)
3.34
+0.04
(+1.21%)
USD |
NASDAQ |
Apr 08, 16:00
3.35
+0.01
(+0.30%)
After-Hours: 20:00
AN2 Therapeutics EPS Diluted (Quarterly) : -0.2869 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Relmada Therapeutics, Inc. | -0.2911 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.71M |
| Total Expenses (Quarterly) | 8.71M |
| Enterprise Value | 62.04M |
| Earnings Yield | -34.34% |
| Normalized Earnings Yield | -34.34 |